DIA 2019 Global Annual Meeting
June 23-27, 2019 | San Diego, CA
The DIA 2019 Global Annual Meeting brings together thousands of innovators from around the globe. Designed to drive insights into action by connecting key policy discussions to real-world knowledge that you need to do your job every day, your attendance will accelerate your growth and your organization’s performance in the development ecosystem.
Download the DIA 2019 Global Annual Meeting Schedule At-A-Glance for session times and to help plan out your days. Download >>
Join Avoca for the Following Sessions:
Monday, June 24 | 11:00am – 12:00pm
Component Type: Forum
Chair: Jay Turpen, Senior Consultant, The Avoca Group
Learning Objectives: Discuss the differing characteristics of a QMS based on the size of the organization; Compare how these characteristics changed in preparation for ICH E6 R2 implementation; Determine whether risk-based approaches vary based on organizational size and what organizations of different sizes can learn from each other.
RJ Doornbos, Head of Global Quality Systems, Global Quality, BMS
Michael Husovich, Director, Global R&D Quality, Amgen Inc.
Lenna Kimball, Vice President of Clinical Operations, Lyell Biotech
Monday, June 24 | 3:30pm – 4:30pm
Component Type: Forum
Learning Objectives: Demonstrate how periodic screenings are an important part of inspection readiness; Discuss where hidden challenges lurk and how mock inspections can bring these items to light; Identify appropriate remediation plans that are organizationally focused and not study specific.
Grace Crawford, Vice President, Clinical Quality and Compliance, MedImmune
Barbara Maley, Senior Consultant, The Avoca Group
Tuesday, June 25 | 8:00am – 9:15am
Component Type: Workshop
Chair: Dawn Auerbach, Executive Director, Client Development, The Avoca Group
Learning Objectives: Identify your DISC personality type; Identify strategies for analyzing the situation from an alternative viewpoint/DISC type to facilitate change management and adoption; Discuss how personality type variations in clinical trial execution impact risk-based approach implementation and may be leveraged for success.
To schedule a meeting with an Avoca representative at DIA 2019, contact us.